Literature DB >> 9380211

[Treatment of patients with thromboses of the basilar artery and locked-in syndrome. An ethical dilemma].

A Thiel1, H Schmidt, H Prange, R Nau.   

Abstract

Decisions regarding the extent of treatment of severely ill patients can be an ethical dilemma when life-prolonging intensive care contradicts the goal of avoiding unnecessary suffering on the part of the patient. Here we present the results of a written survey of physicians on neurological intensive care units in Germany regarding the treatment of patients with basilar artery thrombosis and locked-in syndrome. 52% of the 93 physicians who replied advocated not treating severe infections with antibiotics, 38% were in favor of stopping intensive care. In contrast, 55% recommended intubating the patient in the presence of swallowing disturbances and imminent aspiration. 58% were in favor of discussing these problems in detail with the patient, and 87% advocated discussing them with relatives. Nearly all physicians (97%) recommended using adequate amounts of opiates and benzodiazepines. In very rare cases, 99% would agree to the use of passive euthanasia and 19% to active euthanasia. These findings illustrate the current disagreement on some of the important treatment decisions among physicians on neurological intensive care units. An open exchange of views on these questions could facilitate the appropriate consideration of ethical matters in the treatment of these patients.

Entities:  

Mesh:

Year:  1997        PMID: 9380211     DOI: 10.1007/s001150050176

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  2 in total

1.  Locked-in Syndrome and Blue Toe Syndrome Caused by Cardiopulmonary Bypass.

Authors:  Feridoun Sabzi; Abdolrasoul Moloudi
Journal:  J Tehran Heart Cent       Date:  2010-08-31

2.  Mechanical thrombectomy for basilar artery occlusion: efficacy, outcomes, and futile recanalization in comparison with the anterior circulation.

Authors:  Thomas Raphael Meinel; Johannes Kaesmacher; Jan Gralla; Urs Fischer; Panagiotis Chaloulos-Iakovidis; Leonidas Panos; Pasquale Mordasini; Pascal J Mosimann; Patrik Michel; Steven Hajdu; Marc Ribo; Manuel Requena; Christian Maegerlein; Benjamin Friedrich; Vincent Costalat; Amel Benali; Laurent Pierot; Matthias Gawlitza; Joanna Schaafsma; Vitor M Pereira
Journal:  J Neurointerv Surg       Date:  2019-06-25       Impact factor: 5.836

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.